Indian drug company completes CB buyback

Jubilant Organosys repurchases $48.3 million worth of convertible bonds and becomes the first Indian company to buy back CBs through a tender offer.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES